Opportunistic Infections Citation List: August 17 - August 30, 2012

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. In Vitro Antifungal Activity of the Flavonoid Baicalein against Candida Species. Serpa, R., E.J. Franca, L. Furlaneto-Maia, C.G. Andrade, A. Diniz, and M.C. Furlaneto. Journal of Medical Microbiology, 2012. [Epub ahead of print]. PMID[22918868].

[PubMed]. OI_0817-0830.

2. New Quinolinyl-1,3,4-oxadiazoles: Synthesis, in Vitro Antibacterial, Antifungal and Antituberculosis Studies. Patel, R.V., P. Kumari, and K.H. Chikhalia. Medicinal Chemistry (Shariqah (United Arab Emirates)), 2012. [Epub ahead of print]. PMID[22921108].

[PubMed]. OI_0817-0830.

3. Identification of Antifungal Niphimycin from Streptomyces Sp. Kp6107 by Screening Based on Adenylate Kinase Assay. Kim, H.Y., J.D. Kim, J.S. Hong, J.H. Ham, and B.S. Kim. Journal of Basic Microbiology, 2012. [Epub ahead of print]. PMID[22915202].

[PubMed]. OI_0817-0830.

4. Effects of Undecylenic acid Released from Denture Liner on Candida Biofilms. Goncalves, L.M., A.A. Del Bel Cury, A. Sartoratto, V.L. Garcia Rehder, and W.J. Silva. Journal of Dental Research, 2012. [Epub ahead of print]. PMID[22904206].

[PubMed]. OI_0817-0830.

5. Gain-of-function Mutations in Upc2 Are a Frequent Cause of Erg11 Upregulation in Azole-resistant Clinical Isolates of Candida albicans. Flowers, S.A., K.S. Barker, E.L. Berkow, G. Toner, S.G. Chadwick, S.E. Gygax, J. Morschhauser, and P.D. Rogers. Eukaryotic Cell, 2012. [Epub ahead of print]. PMID[22923048].

[PubMed]. OI_0817-0830.

6. Activity of Spray-dried Microparticles Containing Pomegranate Peel Extract against Candida albicans. Endo, E.H., T. Ueda-Nakamura, C.V. Nakamura, and B.P. Filho. Molecules, 2012. 17(9): p. 10094-10107. PMID[22922280].

[PubMed]. OI_0817-0830.

7. The Fungicide Fludioxonil Antagonizes Fluconazole Activity in the Human Fungal Pathogen Candida albicans. Buschart, A., A. Burakowska, and U. Bilitewski. Journal of Medical Microbiology, 2012. [Epub ahead of print]. PMID[22918865].

[PubMed]. OI_0817-0830.

8. Design of a Candida albicans Disaccharide Conjugate Vaccine by Reverse Engineering a Protective Monoclonal Antibody. Bundle, D.R., C. Nycholat, C. Costello, R. Rennie, and T. Lipinski. ACS Chemical Biology, 2012. [Epub ahead of print]. PMID[22877569].

[PubMed]. OI_0817-0830.

9. The Effect and Safety of Dressing Composed by Nylon Threads Covered with Metallic Silver in Wound Treatment. Brogliato, A.R., P.A. Borges, J.F. Barros, M. Lanzetti, S. Valenca, N.C. Oliveira, H.J. Izario-Filho, and C.F. Benjamim. International Wound Journal, 2012. [Epub ahead of print]. PMID[22905783].

[PubMed]. OI_0817-0830.

10. Differential Chlorate Inhibition of Chaetomium globosum Germination, Hyphal Growth, and Perithecia Synthesis. Biles, C.L., D. Wright, M. Fuego, A. Guinn, T. Cluck, J. Young, M. Martin, J. Biles, and S. Poudyal. Mycopathologia, 2012. [Epub ahead of print]. PMID[22903379].

[PubMed]. OI_0817-0830.

11. Evaluation of Bioactive Potential of an Aloe Vera Sterol Extract. Bawankar, R., V.C. Deepti, P. Singh, R. Subashkumar, G. Vivekanandhan, and S. Babu. Phytotherapy Research, 2012. [Epub ahead of print]. PMID[22899575].

[PubMed]. OI_0817-0830.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

12. The First Synthesis of an Epidiselenodiketopiperazine. McMahon, T.C., S. Stanley, E. Kazyanskaya, D. Hung, and J.L. Wood. Organic letters, 2012. [Epub ahead of print]. PMID[22913407].

[PubMed]. OI_0817-0830.

13. In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis. Lechartier, B., R.C. Hartkoorn, and S.T. Cole. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]. PMID[22926573].

[PubMed]. OI_0817-0830.

14. Meropenem Inhibits D,D-Carboxypeptidase Activity in Mycobacterium tuberculosis. Kumar, P., K. Arora, J.R. Lloyd, I.Y. Lee, V. Nair, E. Fischer, H.I. Boshoff, and C.E. Barry, 3rd. Molecular Microbiology, 2012. [Epub ahead of print]. PMID[22906310].

[PubMed]. OI_0817-0830.

15. Identification of Anti-tubercular Benzothiazinone Compounds by Ligand-based Design. Karoli, T., B. Becker, J. Zuegg, U. Moellmann, S. Ramu, J.X. Huang, and M.A. Cooper. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]. PMID[22916795].

[PubMed]. OI_0817-0830.

16. Syntheses of Mycobactin Analogs as Potent and Selective Inhibitors of Mycobacterium tuberculosis. Juarez-Hernandez, R.E., S.G. Franzblau, and M.J. Miller. Organic & Biomolecular Chemistry, 2012. [Epub ahead of print]. PMID[22895786].

[PubMed]. OI_0817-0830.

17. Antimycobacterials from Lovage Root (Ligusticum officinale Koch). Guzman, J.D., D. Evangelopoulos, A. Gupta, J.M. Prieto, S. Gibbons, and S. Bhakta. Phytotherapy Research, 2012. [Epub ahead of print]. PMID[22899555].

[PubMed]. OI_0817-0830.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

18. Bioisosteric Transformations and Permutations in the Triazolopyrimidine Scaffold to Identify the Minimum Pharmacophore Required for Inhibitory Activity against Plasmodium falciparum Dihydroorotate Dehydrogenase. Marwaha, A., J. White, F. El Mazouni, S.A. Creason, S. Kokkonda, F.S. Buckner, S.A. Charman, M.A. Phillips, and P.K. Rathod. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]. PMID[22877245].

[PubMed]. OI_0817-0830.

19. Anti-plasmodial Activity of Dicoma tomentosa (Asteraceae) and Identification of Urospermal A-15- O-acetate as the Main Active Compound. Jansen, O., M. Tits, L. Angenot, J.P. Nicolas, P. De Mol, J.B. Nikiema, and M. Frederich. Malaria journal, 2012. 11(1): p. 289. PMID[22909422].

[PubMed]. OI_0817-0830.

20. Pentacyclic Ingamine Alkaloids, a New Antiplasmodial Pharmacophore from the Marine Sponge Petrosid ng5 sp5. Ilias, M., M.A. Ibrahim, S.I. Khan, M.R. Jacob, B.L. Tekwani, L.A. Walker, and V. Samoylenko. Planta Medica, 2012. [Epub ahead of print]. PMID[22903383].

[PubMed]. OI_0817-0830.

21. Sickle Cell Micrornas Inhibit the Malaria Parasite. Duraisingh, M.T. and H.F. Lodish. Cell host & Microbe, 2012. 12(2): p. 127-128. PMID[22901533].

[PubMed]. OI_0817-0830.

22. In Vitro and in Vivo Evaluation of a Primaquine Prodrug without Red Blood Cells Membrane Destabilization Property. Davanco, M.G., M.L. de Campos, M.A. Nogueira, S.L. Campos, R.V. Marques, J.L. Dos Santos, C.M. Chin, L.M. da Fonseca, and R.G. Peccinini. Biopharmaceutics & Drug Disposition, 2012. [Epub ahead of print]. PMID[22899089].

[PubMed]. OI_0817-0830.

23. Goniomedines A and B: Unprecedented Bisindole Alkaloids Formed through Fusion of Two Indole Moieties Via a Dihydropyran Unit. Beniddir, M.A., M.T. Martin, M.E. Tran Huu Dau, P. Grellier, P. Rasoanaivo, F. Gueritte, and M. Litaudon. Organic Letters, 2012. 14(16): p. 4162-4165. PMID[22866915].

[PubMed]. OI_0817-0830.

ANTIPROTOZOAL COMPOUNDS

24. Benzoylbenzimidazole-based Selective Inhibitors Targeting Cryptosporidium parvum and Toxoplasma gondii Calcium-dependent Protein Kinase-1. Zhang, Z., K.K. Ojo, S.M. Johnson, E.T. Larson, P. He, J.A. Geiger, A. Castellanos-Gonzalez, A.C. White, Jr., M. Parsons, E.A. Merritt, D.J. Maly, C.L. Verlinde, W.C. Van Voorhis, and E. Fan. Bioorganic & Medicinal Chemistry Letters, 2012. 22(16): p. 5264-5267. PMID[22795629].

[PubMed]. OI_0817-0830.

25. Burden of Disease from Cryptosporidiosis. Shirley, D.A., S.N. Moonah, and K.L. Kotloff. Current Opinion in Infectious Diseases, 2012. [Epub ahead of print]. PMID[22907279].

[PubMed]. OI_0817-0830.

26. A Focused Small Molecule Screen Identifies 14 Compounds with Distinct Effects on Toxoplasma gondii. Kamau, E.T., A.R. Srinivasan, M.J. Brown, M.G. Fair, E.C. Caraher, and J.P. Boyle. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]. PMID[22908155].

[PubMed]. OI_0817-0830.

Citations from the ISI Web of Knowledge Listings for O.I.

27. Biochemical and Molecular Characterization of the Pyrimidine Biosynthetic Enzyme Dihydroorotate Dehydrogenase from Toxoplasma gondii. Triana, M.A.H., M.H. Huynh, M.F. Garavito, B.A. Fox, D.J. Bzik, V.B. Carruthers, M. Loffler, and B.H. Zimmermann. Molecular and Biochemical Parasitology, 2012. 184(2): p. 71-81. ISI[000306626300002].

[WOS]. OI_0817-0830.

28. Antioxidant Activity, Polyphenols Content and Antimicrobial Activity of Several Native Pteridophytes of Romania. Soare, L.C., M. Ferdes, S. Stefanov, Z. Denkova, R. Nicolova, P. Denev, C. Bejan, and A. Paunescu. Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 2012. 40(1): p. 53-57. ISI[000306538900007].

[WOS]. OI_0817-0830.

29. The Fatty acid 8,11-diol Synthase of Aspergillus fumigatus Is Inhibited by Imidazole Derivatives and Unrelated to Ppob. Jerneren, F. and E.H. Oliw. Lipids, 2012. 47(7): p. 707-717. ISI[000306789400007].

[WOS]. OI_0817-0830.

30. Antifungal Activity and Cytotoxicity of Zinc, Calcium, or Copper Alginate Fibers. Gong, Y., G.T. Han, Y.M. Zhang, Y. Pan, X.B. Li, Y.Z. Xia, and Y. Wu. Biological Trace Element Research, 2012. 148(3): p. 415-419. ISI[000306543300019].

[WOS]. OI_0817-0830.

31. Alpha-amino acid-derived 2-Phenylimidazoles with Potential Antimycobacterial Activity. Cvejn, D., V. Klimesova, and F. Bures. Central European Journal of Chemistry, 2012. 10(5): p. 1681-1687. ISI[000306695700033].

[WOS]. OI_0817-0830.

32. Synthesis, Characterization, Antibacterial and Antifungal Activity of Yttrium(III) Complexes Including 1,10-Phenanthroline. Cai, M.J., J.D. Chen, and M. Taha. Chinese Journal of Chemistry, 2012. 30(7): p. 1531-1538. ISI[000306562300027].

[WOS]. OI_0817-0830.

33. Antifungal Activity and Detailed Chemical Characterization of Cistus ladanifer Phenolic Extracts. Barros, L., M. Duenas, C.T. Alves, S. Silva, M. Henriques, C. Santos-Buelga, and I. Ferreira. Industrial Crops and Products, 2012. 41: p. 41-45. ISI[000306681100006].

[WOS]. OI_0817-0830.